119 related articles for article (PubMed ID: 37724003)
1. LC-MS/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid.
Yang YL; Qian ZY; Zhao Y; Chen XL; Huang QY; Guo YJ; Sun LN; Wang YQ
Biomed Chromatogr; 2023 Dec; 37(12):e5738. PubMed ID: 37724003
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.
Sun LN; Zhao Y; Qian ZY; Chen XL; Ma H; Guo YJ; Shen H; Wang YQ
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770870
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Venetoclax for Therapeutic Drug Monitoring in Chinese Acute Myeloid Leukemia Patients by a Validated UPLC-MS/MS Method.
Yang X; Mei C; He X; He L; Lu X; Tong H; Lou Y
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268708
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MS.
de Leeuw SP; de Bruijn P; Koolen SLW; Dingemans AC; Mathijssen RHJ; Veerman GDM
J Pharm Biomed Anal; 2023 Feb; 225():115233. PubMed ID: 36638566
[TBL] [Abstract][Full Text] [Related]
5. Determination of olverembatinib in human plasma and cerebrospinal fluid by an LC-MS/MS method: Validation and clinical application.
Xiang D; Zhao T; Wang J; Cao Y; Yu Q; Liu L; Yu H; Li X; Li N; Yi Y; Gong X
J Pharm Biomed Anal; 2023 Jun; 230():115382. PubMed ID: 37060798
[TBL] [Abstract][Full Text] [Related]
6. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
7. [Determination of sixteen antibiotics and four
Li ZH; Hu XJ; Lu YF; Xie LN; Zhu Y
Se Pu; 2023 May; 41(5):397-408. PubMed ID: 37087605
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumors.
Zhong B; Campagne O; Salloum R; Purzner T; Stewart CF
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122254. PubMed ID: 32615532
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry.
Hanpithakpong W; Day NPJ; White NJ; Tarning J
Malar J; 2022 Jun; 21(1):169. PubMed ID: 35659684
[TBL] [Abstract][Full Text] [Related]
10. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
12. Determination of isoscoparin in mouse blood using UPLC-MS/MS and its pharmacokinetics.
Huang X; Jiang H; Liang Q; Ma Y; Wang X
Biomed Chromatogr; 2022 Sep; 36(9):e5419. PubMed ID: 35638105
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of bentysrepinine (Y101) and its metabolites M8 and M9 in human plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Liu X; Huang C; Xue L; Xu Q; Xia W; Li X; Miao L
J Pharm Biomed Anal; 2018 Feb; 150():287-293. PubMed ID: 29258048
[TBL] [Abstract][Full Text] [Related]
14. Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma.
Sikkema BJ; Mathijssen RHJ; Robbrecht DGJ; Perera TPS; Koolen SLW; de Bruijn P
J Pharm Biomed Anal; 2024 Mar; 240():115962. PubMed ID: 38211518
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a gamma-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions.
Gu H; Deng Y; Wang J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2319-26. PubMed ID: 20674522
[TBL] [Abstract][Full Text] [Related]
16. A validated UPLC-MS/MS method for the determination of CX3002 in human plasma and its application to a pharmacokinetic study.
Hu X; Xu Y; Chen J; Shen Y; Yang D; Hu Y; Jiang B; Lou H; Ruan Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1183():122954. PubMed ID: 34628186
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samples.
Tsuchiya K; Ohuchi M; Yamane N; Aikawa H; Gatanaga H; Oka S; Hamada A
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28762239
[TBL] [Abstract][Full Text] [Related]
18. Determination and pharmacokinetic study of riociguat by UPLC-MS/MS in human plasma.
Kocak OF; Albayrak M; Yaman ME; Atila A; Kadioglu Y; Araz O
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1210():123454. PubMed ID: 36095936
[TBL] [Abstract][Full Text] [Related]
19. A validated LC-MS/MS method for the determination of specnuezhenide and salidroside in rat plasma and its application to a pharmacokinetic study.
Ding Y; Ju Z; Ma C
Biomed Chromatogr; 2018 Dec; 32(12):e4353. PubMed ID: 30062793
[TBL] [Abstract][Full Text] [Related]
20. Determination of vandetanib in human plasma and cerebrospinal fluid by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS).
Bai F; Johnson J; Wang F; Yang L; Broniscer A; Stewart CF
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2561-6. PubMed ID: 21803003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
